You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 24, 2024

Investigational Drug Information for VERU-111


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for VERU-111?

VERU-111 is an investigational drug.

There have been 6 clinical trials for VERU-111. The most recent clinical trial was a Phase 2 trial, which was initiated on June 24th 2021.

The most common disease conditions in clinical trials are Coronavirus Infections, Prostatic Neoplasms, and Severe Acute Respiratory Syndrome. The leading clinical trial sponsors are Veru Inc. and [disabled in preview].

There are eight US patents protecting this investigational drug and one hundred international patents.

Recent Clinical Trials for VERU-111
TitleSponsorPhase
P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .Veru Inc.Phase 2
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast CancerVeru Inc.Phase 2
Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting AgentVeru Inc.Phase 3

See all VERU-111 clinical trials

Clinical Trial Summary for VERU-111

Top disease conditions for VERU-111
Top clinical trial sponsors for VERU-111

See all VERU-111 clinical trials

US Patents for VERU-111

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
VERU-111 ⤷  Sign Up Compounds for treatment of cancer UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, TN) ⤷  Sign Up
VERU-111 ⤷  Sign Up Compounds for treatment of cancer GTX, INC. (Memphis, TN) UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Noxville, TN) ⤷  Sign Up
VERU-111 ⤷  Sign Up Compounds for treatment of cancer UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, TN) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.